BiotechTube

Ropivacaine 0.1% + Ropivacaine 0.4%

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Relatively Healthy Volunteers

Conditions

Relatively Healthy Volunteers

Trial Timeline

Jul 1, 2013 → Nov 1, 2013

NCT ID
NCT01898689

About Ropivacaine 0.1% + Ropivacaine 0.4%

Ropivacaine 0.1% + Ropivacaine 0.4% is a approved stage product being developed by Baxter for Relatively Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT01898689. Target conditions include Relatively Healthy Volunteers.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01898689ApprovedCompleted

Other Products from Baxter

FLOSEAL Hemostatic Matrix + Standard of careApproved
82
Esmolol + MetoprololApproved
82
Fibrin Sealant (Tisseel) used in the Experimental Arm.Approved
82
Sevoflurane + propofol + remifentanilApproved
82
Physioneal + Dianeal + Extraneal + NutrinealApproved
82